LNH Pharma A Trusted Partner.

Slides:



Advertisements
Similar presentations
CMRSC Division of Hematology/Oncology
Advertisements

Project Quality Plans Gillian Sandilands Director of Quality
Essential Documentation GCP Training Seminar 12th October 2011
Tips to a Successful Monitoring Visit
HT Pharmaceuticals Clinical Research Consulting Humphrey Tebit, Principal.
Dr. M. Iwasaki 1 Asian Multinational Clinical Trials - Current Status & Future Direction - Dr.Masaru IWASAKI PR Japan Operations Center Aventis Pharma,
The Early Phase (0-I-II) Clinical Drug Research Unit of Maastricht University Medical Center (MUMC) prof dr L. Van Bortel Drug Research Unit Maastricht.
Audit Ebru Mutlu-Omega CRO. General Purpose to help quality (to maintain quality at present) to assure quality (make sure that quality in future is maintained)
Clinical QA Data Audits A GCP Point of View Linda Del Paggio GCP Compliance BioBridges, LLC.
1st Global QA Conference & 21st SQA Annual Meeting Falcon Consulting Group, LLC 1 Phase I Clinical Study Audits “A Deeper Scrutiny” Cheryl J. Priest, R.N.
David Cloutier Director, Research Center Management and Development Budgeting for Industry Sponsored Clinical Trials.
Jeevan Scientific Technology Limited
Good Clinical Practices Regulatory Guidelines for the Conduct of Clinical research Introduction to Research Pharmacy Services Javier Palacios, R.Ph. Sponsored.
Monitoring and Auditing
EDC PHARMA SERVICES Capacity. Expertise. Solutions. Technology.
Developed by Klinikos; Roy Fraser (2012) Investigator Study File
Managing Sponsorship Research Services University of Oxford.
Tipologie di Audit e loro caratteristiche Riunione sottogruppo GCP-GIQAR 21 Marzo 2006 Francesca Bucchi.
The “ Operon Strategist” is working towards the catalyzing and ensuring the strategic development of the clients in the areas of Regulatory approvals,
Session 6: Data Integrity and Inspection of e-Clinical Computerized Systems May 15, 2011 | Beijing, China Kim Nitahara Principal Consultant and CEO META.
Healing Hands Clinical Research Services is a Site Management organization with broad spectrum of activities.
Why companies saying or should say “YES” to India for Studies.
Coordinator University Clinical Research Pharmacy Investigational Drug Service (IDS) Marjorie Shaw Phillips, MS, RPh, FASHP Clinical Research Pharmacist.
Federal Institute for Drugs and Medical Devices The BfArM is a Federal Institute within the portfolio of the Federal Ministry of Health 1 Quality of Bioequivalence.
Protocol Complexity as a Factor in Vendor Management Compliance Risk
Assessment of Interchangeable Multisource Medicines Quality of BE Data Dr. Henrike Potthast Training workshop: Assessment of Interchangeable.
Recapture of Day 1 Suchart Chongprasert, Ph.D. Food and Drug Administration “Practical Aspects in Performing Clinical and Bioanalytical Parts in BA/BE.
Good Clinical Practice (GCP)- An introduction Dr Noor Ibrahim Mohamed Sakian.
By J.Thitiri KEMRI-Wellcome Trust Research Programme Kilifi, Kenya PHARMACY AND PRODUCT ACCOUNTABILITY Version: 14-Nov-2009.
Target Institute of Medical Education & Research (TIMER) Provides Clinical Research services to Pharmaceutical, Biotechnology product companies right.
Jasper Ogwal-Okeng Gulu University Research Workshop 3 rd -6 th March 08.
A S Nanivadekar Introduction to GCP. A S Nanivadekar Outline Definition and scope Definition and scope Purpose of clinical research Purpose of clinical.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
MODULE I Close-Out Visit/Monitoring Reports Jane Fendl April 24, Versions: Final 24-Apr-2010.
PRODUCT TRANSFER.
T16 Phase I studies – Phase I units and you, a Phase I unit’s expectation – A Day in the Life of a Phase I Study Coordinator Jeffery Wong, Clinical Research.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
SIPLAS RO is a full service contract research organization CRO, offering nanotechnology, biopharmaceutical and medical device companies comprehensive.
1. Re-Use of Clinical Care and of Clinical Trial Data A Contract Research Organisation (CRO) point of view EuroRec Conference 2009 Sarajevo Selina Sibbald.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
MEDICAL experts INDUSTRY Some of our clients. Pharmaceutical companies, manufacturers of medical and surgical devices, clinical research organizations,
Cancer Centers In Clinical Trials Sandrine Marreaud Head of Medical Department.
Training Workshop: Training of BE Assessors Kiev, October 2009 Frequent Deficiencies Dr. Henrike Potthast Training workshop: Training.
Development and Approval of Drugs and Devices EPI260 Lecture 6: Late Phase Clinical Trials April 28, 2011 Richard Chin, M.D.
Study Closure Process Entropy is not a method Rachel Sheppard Regulatory Director, OCRSS.
Bundesinstitut für Arzneimittel und Medizinprodukte Pt WHO-consultant 1 WHO Training Workshop on Pharmaceutical Quality, Good Manufacturing Practice &
How to Start An Industry Sponsored Clinical Trial
CONDUCTING COMPLIANCE ASSESSMENTS Allen Ditch Director Corporate Quality Bristol Myers Squibb Medical Research Summit March 6, 2003.
Korea Food & Drug Administration Deputy director Kwang-Soo Joo Korea FDA Sep. 29, 2000 : Korean Good Clinical Practice & Relative Guidelines How to Manage.
GCP (GOOD CLINICAL PRACTISE)
Business Considerations in eTMF Implementation Karen Roy Phlexglobal Ltd.
Responsibilities of Sponsor, Investigator and Monitor
Process-based Metadata From a DIA Presentation: eTMF – Migrating from Paper Trial Master Files to Electronic Eldin Rammell, Managing Director, Rammell.
Tanzania, August 2006 Dr. Barbara Sterzik, BfArM, Bonn 1 Bioequivalence dossier requirements for the prequalification project WHO Training Workshop.
September 18, 2009 Prepared for DIA GCP QA SIAC teleconference 1 GCP QA for Russia and the Ukraine.
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
Lisa Hoebelheinrich, JD, CHRC Associate Vice Chancellor, Compliance
Responsibilities of Sponsor, Investigator and Monitor
ISO/IEC
MAINTAINING THE INVESTIGATOR’S SITE FILE
Vikas Dhikav, PhD Clinical Trials Vikas Dhikav, PhD
The Information Professional’s Role in Product Safety
Good Clinical Practice
Lesson 5: BRITE Seminar: GMP II
Global PRESENCE LATE PHASE SERVICES China Switzerland Philippines USA
CLINICAL DATA MANAGEMENT
Elements of an Organized Regulatory Binder
MAINTAINING THE INVESTIGATOR’S STUDY FILE
Clinical Research Around the World
Presentation transcript:

LNH Pharma A Trusted Partner

ABOUT US LNH Pharma is a Global pharma services company , provide a broad range of clinical research services for clinical and generic product development for Pharma/Biotech industries for introducing generic and new drug products. LNH Pharma Mission: To deliver value added , reliable and cost effective services for the clients. Vision: To be an integrated services company with global distinction , aiming for long term partnership with clients Values: Quality, Integrity, commitment and accountability.

Organization Structure CEO COO HR Executives BD

System & Procedures The LNH Pharma has quality procedures in place for services being performed . All the procedures are established as per different regulatory and study specific requirements. All the procedures are being updated as when required or on regular basis as per the changes in regulatory norms and guidelines. The procedures are being prepared and updated as per the Client specific requirements for meeting study requirements within the quality management system.

OUR PEOPLE Dr. Vasu.Kandati, M.Pharm(Pharmacology) , Ph.D COO Mr.Tiruvendra.S BD-Director Advisors: Prasad.CH, Clinical Trial Specialist Srinivasa Rao Pathuri, Formulation Specialist Dr.Varaprasda, Bioanalytical Specialist

LNH Pharma Services

PROJECT MANAGEMENT BA/BE TRIALS: Checking CRO feasibility for slots and study requirements. Identification, selection and Qualification of CROs. Protocol review and Finalization as per Regulatory requirements. Coordinating with CROs for BENOC &T-License , Protocol approval By Ethics committee and DCG(I) Coordinating with sponsor & CROs for IP management as per the Regulatory requirements.

Monitoring of CLINICAL STUDY EXECUTION PROJECT MANAGEMENT Monitoring of CLINICAL STUDY EXECUTION Check-in process Dispensing Dosing Phlebotomy activities Check out process Ensuring storage and retention quantity of IPs for regulatory inspections with CROs.

PROJECT MANAGEMENT Monitoring of BIOANALYTICAL STUDY EXECUTION METHOD VALIDATION includes monitoring of processing for P&A batches, Extended P&A batch, Stabilities and Matrix effect. PROJECT SAMPLE ANALYSIS includes monitoring of processing or regular analysis, Repeat analysis, Individual repeats and Incurred sample reanalysis.

PROJECT MANAGEMENT AUDIT AND COMPLIANCE Perform retrospective audit of Clinical data includes review of Medical screening records, Case Report Forms, Logbooks and essential documents in trial master file. Perform review of Clinical study report and SDTM data as per CDISCO requirements. Perform retrospective audit of Method validation data includes Method validation trial documents, MV Chromatograms, Audit trials, Logbooks and Method Validation report.

PROJECT MANAGEMENT AUDIT AND COMPLIANCE Perform retrospective audit of project sample analysis data includes Sample analysis trial documents, Chromatograms, Repeat Analysis documents, Incurred sample analysis, Audit trails, Logbooks and BA report. Review of e-CTD report with STDM format as per CDISCO requirements.

PROJECT MANAGEMENT CLINICAL TRIALS Site identification and Qualification Site initiation Budget and contract negotiation Regulatory document preparation and collection Investigator meeting planning and presentation Site personnel training Interim site monitoring visits

PROJECT MANAGEMENT CLINICAL TRIALS Site closure Clinical study material retention, storage and accountability as per regulatory requirements. Monitoring of Bioanalytical study execution includes method validation and project sample analysis Handling of regulatory queries and coordinating for regulatory inspections.

PROJECT MANAGEMENT CLINICAL TRIALS: Audit and Compliance Review of patient records, source data, Paper CRFs, e-CRFs, essential documents in SMF&TMF. Review of Clinical study report including Annexures as per CDISCO requirements. Review of Bioanalytical data ,Validation data and BA report as per the protocol and study requirements.

MONITORING BA/BE TRIALS: Food effect studies and Fasting studies Multiple dose studies Dose escalation studies Drug-Drug interaction studies Special population studies like post -menopausal and psychiatric studies

MONITORING BA/BE TRIALS : BE studies with special requirements like cardiac monitoring. BE trials for all major therapeutic areas

MONITORING CLINICAL TRIALS: Patient population PK studies (Patient BE studies) Patient population PD studies (Clinical end point studies) Clinical trials including Phase1, Phase 11-A,11-B and Phase111 for all major therapeutic areas.

REGULATORY QUERIES Response for Product and Facility based inspections for different health regulatory authorities (But not limited) including USFDA, EMEA, UK-MHRA, MCC, ANVISA, Health Canada, DCG (I), MoH-Malaysia, MoH-Turkey, Rest of the world and other regulatories. Dossiers for BE-NOC/CT-NOC,T-License and Facility approvals like DCG (I), MoH-Turkey, MoH-Malaysia, GCC and ANVISA. Regulatory consultancy for clinical trial and BA/BE trials.

CRO AND INVESTIGATIONAL SITE ESTABLISHMENT Support and Guide the sponsors /Hospitals/Investigators for establishing CRO and Investigator site as per regulatory requirements. Design the systems, process, procedures and facility as per the different regulatory requirements and Client need. Review and support for Qualification and validation of instruments/equipments.

CRO AND INVESTIGATIONAL SITE QUALIFICATION Qualify CRO and Investigator sites in India and Abroad for the national and international clients as per the regulatory and study requirements. Prepare the CRO and investigational site before hand for the product and facility based inspections as per different regulatory and study requirements.

AUDIT AND COMPLIANCE Perform the retrospective audit of clinical data including Medical screening records, Case Report Forms and Trial Master file essential documents. Review of Clinical study report as per CDISCO requirements. Perform retrospective audit of method validation data including Method validation trial documents, MV Chromatograms, Audit trials, Logbooks and Method Validation report.

AUDIT AND COMPLIANCE Perform retrospective audit of project sample analysis data including Sample analysis trial documents, Chromatograms, Repeat Analysis documents, Incurred sample analysis, Audit trials, Logbooks and BA report. Review of e-CTD report as per CDISCO requirements.

THANK YOU